Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Clark T. Sawin, Andrew Geller, Philip A. Wolf, Albert J. Belanger, Errol Baker, Pamela Bacharach, Peter Wilson, Emelia J. Benjamin, and Ralph B. D'Agostino
Background Low serum thyrotropin concentrations are a sensitiveindicator of hyperthyroidism but can also occur in persons whohave no clinical manifestations of the disorder. We studiedwhether low serum thyrotropin concentrations in clinically euthyroidolder persons are a risk factor for subsequent atrial fibrillation.
Methods We studied 2007 persons (814 men and 1193 women) 60years of age or older who did not have atrial fibrillation inorder to determine the frequency of this arrhythmia during a10-year follow-up period. The subjects were classified accordingto their serum thyrotropin concentrations: those with low values( 0.1 mU per liter; 61 subjects); those with slightly low values(>0.1 to 0.4 mU per liter; 187 subjects); those with normalvalues (>0.4 to 5.0 mU per liter; 1576 subjects); and thosewith high values (>5.0 mU per liter; 183 subjects).
Results During the 10-year follow-up period, atrial fibrillationoccurred in 13 persons with low initial values for serum thyrotropin,23 with slightly low values, 133 with normal values, and 23with high values. The cumulative incidence of atrial fibrillationat 10 years was 28 percent among the subjects with low serumthyrotropin values ( 0.1 mU per liter), as compared with 11percent among those with normal values; the age-adjusted incidenceof atrial fibrillation was 28 per 1000 person-years among thosewith low values and 10 per 1000 person-years among those withnormal values (P = 0.005). After adjustment for other knownrisk factors, the relative risk of atrial fibrillation in elderlysubjects with low serum thyrotropin concentrations, as comparedwith those with normal concentrations, was 3.1 (95 percent confidenceinterval, 1.7 to 5.5; P<0.001). The 10-year incidence ofatrial fibrillation in the groups with slightly low and highserum thyrotropin values was not significantly different fromthat in the group with normal values.
Conclusions Among people 60 years of age or older, a low serumthyrotropin concentration is associated with a threefold higherrisk that atrial fibrillation will develop in the subsequentdecade.
Source Information
From the Medical and Medical Research Services, Boston Veterans Affairs Medical Center, Boston (C.T.S., A.G., E.B., P.B.); the Section of Preventive Medicine and Epidemiology, Evans Memorial Department of Clinical Research (P.A.W.), and the Departments of Neurology (P.A.W.), Mathematics (A.J.B., R.B.D.), and Medicine (C.T.S., E.J.B.), Boston University, Boston; and the Framingham Heart Study, Framingham, Mass. (P.A.W., P.W.F.W.).
Address reprint requests to Dr. Sawin at the Boston Veterans Affairs Medical Center, 150 S. Huntington Ave., Boston, MA 02130.
Mistry, N, Wass, J, Turner, M R
(2009). When to consider thyroid dysfunction in the neurology clinic. PN
9: 145-156
[Abstract][Full Text]
Mitchell, A. L, Pearce, S.
(2009). An elderly woman with weight loss and diarrhoea. BMJ
338: b1721-b1721
[Full Text]
Somwaru, L. L., Arnold, A. M., Joshi, N., Fried, L. P., Cappola, A. R.
(2009). High Frequency of and Factors Associated with Thyroid Hormone Over-Replacement and Under-Replacement in Men and Women Aged 65 and Over. J. Clin. Endocrinol. Metab.
94: 1342-1345
[Abstract][Full Text]
Goichot, B., Sapin, R., Schlienger, J. L.
(2009). Subclinical Hyperthyroidism: Considerations in Defining the Lower Limit of the Thyrotropin Reference Interval. Clin. Chem.
55: 420-424
[Abstract][Full Text]
Heeringa, J., Hoogendoorn, E. H., van der Deure, W. M., Hofman, A., Peeters, R. P., Hop, W. C. J., den Heijer, M., Visser, T. J., Witteman, J. C. M.
(2008). High-Normal Thyroid Function and Risk of Atrial Fibrillation: The Rotterdam Study. Arch Intern Med
168: 2219-2224
[Abstract][Full Text]
Haentjens, P., Van Meerhaeghe, A., Poppe, K., Velkeniers, B.
(2008). Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. Eur J Endocrinol
159: 329-341
[Abstract][Full Text]
Dorr, M., Empen, K., Robinson, D. M, Wallaschofski, H., Felix, S. B, Volzke, H.
(2008). The association of thyroid function with carotid artery plaque burden and strokes in a population-based sample from a previously iodine-deficient area. Eur J Endocrinol
159: 145-152
[Abstract][Full Text]
Tan, Z. S., Beiser, A., Vasan, R. S., Au, R., Auerbach, S., Kiel, D. P., Wolf, P. A., Seshadri, S.
(2008). Thyroid Function and the Risk of Alzheimer Disease: The Framingham Study. Arch Intern Med
168: 1514-1520
[Abstract][Full Text]
Vaidya, B., Pearce, S. H S
(2008). Management of hypothyroidism in adults. BMJ
337: a801-a801
[Full Text]
Ladenson, P. W.
(2008). Cardiovascular Consequences of Subclinical Thyroid Dysfunction: More Smoke but No Fire. ANN INTERN MED
148: 880-881
[Full Text]
Wustmann, K., Kucera, J. P., Zanchi, A., Burow, A., Stuber, T., Chappuis, B., Diem, P., Delacretaz, E.
(2008). Activation of Electrical Triggers of Atrial Fibrillation in Hyperthyroidism. J. Clin. Endocrinol. Metab.
93: 2104-2108
[Abstract][Full Text]
Fox, C. S., Pencina, M. J., D'Agostino, R. B., Murabito, J. M., Seely, E. W., Pearce, E. N., Vasan, R. S.
(2008). Relations of Thyroid Function to Body Weight: Cross-sectional and Longitudinal Observations in a Community-Based Sample. Arch Intern Med
168: 587-592
[Abstract][Full Text]
Biondi, B., Cooper, D. S.
(2008). The Clinical Significance of Subclinical Thyroid Dysfunction. Endocr. Rev.
29: 76-131
[Abstract][Full Text]
Schlechte, J. A.
(2007). Update in Endocrinology. ANN INTERN MED
147: 563-572
[Full Text]
Klein, I., Danzi, S.
(2007). Thyroid Disease and the Heart. Circulation
116: 1725-1735
[Abstract][Full Text]
Cappola, A. R.
(2007). Subclinical Thyroid Dysfunction and the Heart. J. Clin. Endocrinol. Metab.
92: 3404-3405
[Full Text]
Volzke, H., Schwahn, C., Wallaschofski, H., Dorr, M.
(2007). The Association of Thyroid Dysfunction with All-Cause and Circulatory Mortality: Is There a Causal Relationship?. J. Clin. Endocrinol. Metab.
92: 2421-2429
[Abstract][Full Text]
Gammage, M. D., Osman, F., Sheppard, M. C., Franklyn, J. A.
(2007). Reply. J Am Coll Cardiol
49: 2229-2230
[Full Text]
Volzke, H.
(2007). Hyperthyroidism and Mortality. J Am Coll Cardiol
49: 2228-2229
[Full Text]
Gammage, M. D., Parle, J. V., Holder, R. L., Roberts, L. M., Hobbs, F. D. R., Wilson, S., Sheppard, M. C., Franklyn, J. A.
(2007). Association Between Serum Free Thyroxine Concentration and Atrial Fibrillation. Arch Intern Med
167: 928-934
[Abstract][Full Text]
Walter, M. A, Briel, M., Christ-Crain, M., Bonnema, S. J, Connell, J., Cooper, D. S, Bucher, H. C, Muller-Brand, J., Muller, B.
(2007). Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials. BMJ
334: 514-514
[Abstract][Full Text]
Osman, F., Franklyn, J. A., Holder, R. L., Sheppard, M. C., Gammage, M. D.
(2007). Cardiovascular Manifestations of Hyperthyroidism Before and After Antithyroid Therapy: A Matched Case-Control Study. J Am Coll Cardiol
49: 71-81
[Abstract][Full Text]
Cooper, D. S.
(2007). Approach to the Patient with Subclinical Hyperthyroidism. J. Clin. Endocrinol. Metab.
92: 3-9
[Abstract][Full Text]
O'Donnell, M. J., Valens, N., Lansberg, M. G., Wijman, C. A.C.
(2006). Thyroid replacement therapy and atrial fibrillation in acute ischemic stroke.. Neurology
67: 1714-1715
[Full Text]
Cappola, A. R., Fried, L. P., Arnold, A. M., Danese, M. D., Kuller, L. H., Burke, G. L., Tracy, R. P., Ladenson, P. W.
(2006). Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults. JAMA
295: 1033-1041
[Abstract][Full Text]
Dorr, M., Robinson, D. M., Wallaschofski, H., Schwahn, C., John, U., Felix, S. B., Volzke, H.
(2006). Low Serum Thyrotropin Is Associated with High Plasma Fibrinogen. J. Clin. Endocrinol. Metab.
91: 530-534
[Abstract][Full Text]
Hoogendoorn, E. H., Hermus, A. R., de Vegt, F., Ross, H. A., Verbeek, A. L.M., Kiemeney, L. A.L.M., Swinkels, D. W., Sweep, F. C.G.J., den Heijer, M.
(2006). Thyroid Function and Prevalence of Anti-Thyroperoxidase Antibodies in a Population with Borderline Sufficient Iodine Intake: Influences of Age and Sex. Clin. Chem.
52: 104-111
[Abstract][Full Text]
Rodondi, N., Newman, A. B., Vittinghoff, E., de Rekeneire, N., Satterfield, S., Harris, T. B., Bauer, D. C.
(2005). Subclinical Hypothyroidism and the Risk of Heart Failure, Other Cardiovascular Events, and Death. Arch Intern Med
165: 2460-2466
[Abstract][Full Text]
Walsh, J. P., Bremner, A. P., Bulsara, M. K., O'Leary, P., Leedman, P. J., Feddema, P., Michelangeli, V.
(2005). Subclinical Thyroid Dysfunction as a Risk Factor for Cardiovascular Disease. Arch Intern Med
165: 2467-2472
[Abstract][Full Text]
Boelaert, K, Franklyn, J A
(2005). Thyroid hormone in health and disease. J Endocrinol
187: 1-15
[Abstract][Full Text]
Squizzato, A., Gerdes, V.E.A., Brandjes, D.P.M., Buller, H.R., Stam, J.
(2005). Thyroid Diseases and Cerebrovascular Disease. Stroke
36: 2302-2310
[Abstract][Full Text]
Hu, Y., Jones, S. V. P., Dillmann, W. H.
(2005). Effects of hyperthyroidism on delayed rectifier K+ currents in left and right murine atria. Am. J. Physiol. Heart Circ. Physiol.
289: H1448-H1455
[Abstract][Full Text]
Kahaly, G. J., Dillmann, W. H.
(2005). Thyroid Hormone Action in the Heart. Endocr. Rev.
26: 704-728
[Abstract][Full Text]
Franklyn, J. A., Sheppard, M. C., Maisonneuve, P.
(2005). Thyroid Function and Mortality in Patients Treated for Hyperthyroidism. JAMA
294: 71-80
[Abstract][Full Text]
Heijckmann, A C., Huijberts, M. S P, Geusens, P., de Vries, J., Menheere, P. P C A, Wolffenbuttel, B. H R
(2005). Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma. Eur J Endocrinol
153: 23-29
[Abstract][Full Text]
Castro, M. R., Gharib, H.
(2005). Continuing Controversies in the Management of Thyroid Nodules. ANN INTERN MED
142: 926-931
[Abstract][Full Text]
Casu, M., Cappi, C., Patrone, V., Repetto, E., Giusti, M., Minuto, F., Murialdo, G.
(2005). Sympatho-vagal control of heart rate variability in patients treated with suppressive doses of L-thyroxine for thyroid cancer. Eur J Endocrinol
152: 819-824
[Abstract][Full Text]
Krohn, K., Fuhrer, D., Bayer, Y., Eszlinger, M., Brauer, V., Neumann, S., Paschke, R.
(2005). Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter. Endocr. Rev.
26: 504-524
[Abstract][Full Text]
Azizi, F, Ataie, L, Hedayati, M, Mehrabi, Y, Sheikholeslami, F
(2005). Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine. Eur J Endocrinol
152: 695-701
[Abstract][Full Text]
Biondi, B., Palmieri, E. A., Klain, M., Schlumberger, M., Filetti, S., Lombardi, G.
(2005). Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol
152: 1-9
[Abstract][Full Text]
Mandel, S. J.
(2004). A 64-Year-Old Woman With a Thyroid Nodule. JAMA
292: 2632-2642
[Full Text]
Hegedus, L.
(2004). The Thyroid Nodule. NEJM
351: 1764-1771
[Full Text]
Samollow, P. B., Perez, G., Kammerer, C. M., Finegold, D., Zwartjes, P. W., Havill, L. M., Comuzzie, A. G., Mahaney, M. C., Goring, H. H., Blangero, J., Foley, T. P., Barmada, M. M.
(2004). Genetic and Environmental Influences on Thyroid Hormone Variation in Mexican Americans. J. Clin. Endocrinol. Metab.
89: 3276-3284
[Abstract][Full Text]
Hoogendoorn, E H, den Heijer, M, van Dijk, A P J, Hermus, A R
(2004). Subclinical hyperthyroidism: to treat or not to treat?. Postgrad. Med. J.
80: 394-398
[Abstract][Full Text]
Volzke, H., Robinson, D. M., Schminke, U., Ludemann, J., Rettig, R., B. Felix, S., Kessler, C., John, U., Meng, W.
(2004). Thyroid Function and Carotid Wall Thickness. J. Clin. Endocrinol. Metab.
89: 2145-2149
[Abstract][Full Text]
Helfand, M.
(2004). Screening for Subclinical Thyroid Dysfunction in Nonpregnant Adults: A Summary of the Evidence for the U.S. Preventive Services Task Force. ANN INTERN MED
140: 128-141
[Abstract][Full Text]
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., Gorman, C., Cooper, R. S., Weissman, N. J.
(2004). Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management. JAMA
291: 228-238
[Abstract][Full Text]
Col, N. F., Surks, M. I., Daniels, G. H.
(2004). Subclinical Thyroid Disease: Clinical Applications. JAMA
291: 239-243
[Abstract][Full Text]
Fazio, S., Palmieri, E. A., Lombardi, G., Biondi, B.
(2004). Effects of Thyroid Hormone on the Cardiovascular System. Recent Prog Horm Res
59: 31-50
[Abstract][Full Text]
Auer, J., Berent, R., Eber, B.
(2003). Subclinical Thyroid Dysfunction and the Heart. ANN INTERN MED
139: 865-866
[Full Text]
Biondi, B., Palmieri, E. A., Lombardi, G., Fazio, S.
(2003). Subclinical Thyroid Dysfunction and the Heart. ANN INTERN MED
139: 866-867
[Full Text]
Ganotakis, E. S., Mandalaki, K., Tampakaki, M., Malliaraki, N., Mandalakis, E., Vrentzos, G., Melissas, J., Castanas, E.
(2003). Subclinical Hypothyroidism and Lipid Abnormalities in Older Women Attending a Vascular Disease Prevention Clinic: Effect of Thyroid Replacement Therapy. ANGIOLOGY
54: 569-576
[Abstract]
Toft, A D, Beckett, G J
(2003). Thyroid function tests and hypothyroidism: Authors' reply. BMJ
326: 1087-1087
[Full Text]
Crilly, M.
(2003). Thyroid function tests and hypothyroidism: Reducing concentrations further would be harmful. BMJ
326: 1086-1086
[Full Text]
Vanderpump, M. P, Franklyn, J. A
(2003). Thyroid function tests and hypothyroidism: Restoring serum TSH to reference range should be goal of replacement. BMJ
326: 1086-1087
[Full Text]
Sgarbi, J. A., Villaca, F. G., Garbeline, B., Villar, H. E., Romaldini, J. H.
(2003). The Effects of Early Antithyroid Therapy for Endogenous Subclinical Hyperthyroidism in Clinical and Heart Abnormalities. J. Clin. Endocrinol. Metab.
88: 1672-1677
[Abstract][Full Text]
Hegedus, L., Bonnema, S. J., Bennedbaek, F. N.
(2003). Management of Simple Nodular Goiter: Current Status and Future Perspectives. Endocr. Rev.
24: 102-132
[Abstract][Full Text]
Biondi, B., Palmieri, E. A., Lombardi, G., Fazio, S.
(2002). Effects of Subclinical Thyroid Dysfunction on the Heart. ANN INTERN MED
137: 904-914
[Abstract][Full Text]
Wemeau, J.-L., Caron, P., Schvartz, C., Schlienger, J.-L., Orgiazzi, J., Cousty, C., Vlaeminck-Guillem, V.
(2002). Effects of Thyroid-Stimulating Hormone Suppression with Levothyroxine in Reducing the Volume of Solitary Thyroid Nodules and Improving Extranodular Nonpalpable Changes: A Randomized, Double-Blind, Placebo-Controlled Trial by the French Thyroid Research Group. J. Clin. Endocrinol. Metab.
87: 4928-4934
[Abstract][Full Text]
Castro, M. R., Caraballo, P. J., Morris, J. C.
(2002). Effectiveness of Thyroid Hormone Suppressive Therapy in Benign Solitary Thyroid Nodules: A Meta-Analysis. J. Clin. Endocrinol. Metab.
87: 4154-4159
[Abstract][Full Text]
Auer, J., Berent, R., Weber, T., Eber, B.
(2002). Thyroid hormone and arrhythmogenic activity. J Am Coll Cardiol
40: 574-575
[Full Text]
Chen, Y. i-J., Chen, Y.-C., Lin, C.-I., Chen, S.-A.
(2002). Reply. J Am Coll Cardiol
40: 575-575
[Full Text]
Isley, W. L.
(2002). Growth Hormone Therapy for Adults: Not Ready for Prime Time?. ANN INTERN MED
137: 190-196
[Abstract][Full Text]
Aronow, W. S.
(2002). Management of the Older Person With Atrial Fibrillation. Journals of Gerontology Series A: Biological Sciences and Medical Sciences
57: M352-363
[Abstract][Full Text]
Bosch, R. F, Nattel, S.
(2002). Cellular electrophysiology of atrial fibrillation. Cardiovasc Res
54: 259-269
[Full Text]
Osman, F., Gammage, M. D., Sheppard, M. C., Franklyn, J. A.
(2002). Cardiac Dysrhythmias and Thyroid Dysfunction - The Hidden Menace?. J. Clin. Endocrinol. Metab.
87: 963-967
[Abstract][Full Text]
Bonnema, S. J., Bennedbak, F. N., Ladenson, P. W., Hegedus, L.
(2002). Management of the Nontoxic Multinodular Goiter: A North American Survey. J. Clin. Endocrinol. Metab.
87: 112-117
[Abstract][Full Text]
Chu, J. W., Crapo, L. M.
(2001). The Treatment of Subclinical Hypothyroidism Is Seldom Necessary. J. Clin. Endocrinol. Metab.
86: 4591-4599
[Full Text]
Meier, C., Staub, J.-J., Roth, C.-B., Guglielmetti, M., Kunz, M., Miserez, A. R., Drewe, J., Huber, P., Herzog, R., Muller, B.
(2001). TSH-Controlled L-Thyroxine Therapy Reduces Cholesterol Levels and Clinical Symptoms in Subclinical Hypothyroidism: A Double Blind, Placebo-Controlled Trial (Basel Thyroid Study). J. Clin. Endocrinol. Metab.
86: 4860-4866
[Abstract][Full Text]
Toft, A. D.
(2001). Subclinical Hyperthyroidism. NEJM
345: 512-516
[Full Text]
Drake, W. M., Howell, S. J., Monson, J. P., Shalet, S. M.
(2001). Optimizing GH Therapy in Adults and Children. Endocr. Rev.
22: 425-450
[Abstract][Full Text]
Wesche, M. F. T., Tiel-v Buul, M. M. C., Lips, P., Smits, N. J., Wiersinga, W. M.
(2001). A Randomized Trial Comparing Levothyroxine with Radioactive Iodine in the Treatment of Sporadic Nontoxic Goiter. J. Clin. Endocrinol. Metab.
86: 998-1005
[Abstract][Full Text]
Bakker, S. J. L., ter Maaten, J. C., Popp-Snijders, C., Slaets, J. P. J., Heine, R. J., Gans, R. O. B.
(2001). The Relationship between Thyrotropin and Low Density Lipoprotein Cholesterol Is Modified by Insulin Sensitivity in Healthy Euthyroid Subjects. J. Clin. Endocrinol. Metab.
86: 1206-1211
[Abstract][Full Text]
Klein, I., Ojamaa, K.
(2001). Thyroid Hormone and the Cardiovascular System. NEJM
344: 501-509
[Full Text]
Al-Abadi, A C
(2001). Subclinical thyrotoxicosis. Postgrad. Med. J.
77: 29-29
[Full Text]
Biondi, B., Palmieri, E. A., Fazio, S., Cosco, C., Nocera, M., Saccà, L., Filetti, S., Lombardi, G., Perticone, F.
(2000). Endogenous Subclinical Hyperthyroidism Affects Quality of Life and Cardiac Morphology and Function in Young and Middle-Aged Patients. J. Clin. Endocrinol. Metab.
85: 4701-4705
[Abstract][Full Text]
Toft, A D, Boon, N A
(2000). GENERAL CARDIOLOGY: Thyroid disease and the heart. Heart
84: 455-460
[Full Text]
Peters, A., Ehlers, M., Blank, B., Exler, D., Falk, C., Kohlmann, T., Fruehwald-Schultes, B., Wellhoener, P., Kerner, W., Fehm, H. L.
(2000). Excess Triiodothyronine as a Risk Factor of Coronary Events. Arch Intern Med
160: 1993-1999
[Abstract][Full Text]
Ladenson, P. W., Singer, P. A., Ain, K. B., Bagchi, N., Bigos, S. T., Levy, E. G., Smith, S. A., Daniels, G. H.
(2000). American Thyroid Association Guidelines for Detection of Thyroid Dysfunction. Arch Intern Med
160: 1573-1575
[Abstract][Full Text]
Kreuzberg, U., Theissen, P., Schicha, H., Schroder, F., Mehlhorn, U., de Vivie, E. R., Boknik, P., Neumann, J., Grohe, C., Herzig, S.
(2000). Single-channel activity and expression of atrial L-type Ca2+ channels in patients with latent hyperthyroidism. Am. J. Physiol. Heart Circ. Physiol.
278: H723-H730
[Abstract][Full Text]
Canaris, G. J., Manowitz, N. R., Mayor, G., Ridgway, E. C.
(2000). The Colorado Thyroid Disease Prevalence Study. Arch Intern Med
160: 526-534
[Abstract][Full Text]
Bauer, D. C
(2000). Review: sensitive thyrotropin testing in unselected inpatients has low diagnostic accuracy. Evid. Based Med.
5: 29-29
[Full Text]
Hanna, F W F, Lazarus, J H, Scanlon, M F
(1999). Fortnightly review: Controversial aspects of thyroid disease. BMJ
319: 894-899
[Full Text]
Bonnema, S. J., Bertelsen, H., Mortensen, J., Andersen, P. B., Knudsen, D. U., Bastholt, L., Hegedus, L.
(1999). The Feasibility of High Dose Iodine 131 Treatment as an Alternative to Surgery in Patients with a Very Large Goiter: Effect on Thyroid Function and Size and Pulmonary Function. J. Clin. Endocrinol. Metab.
84: 3636-3641
[Abstract][Full Text]
Toft, A. D.
(1999). Thyroid Hormone Replacement -- One Hormone or Two?. NEJM
340: 468-470
[Full Text]
Biondi, B., Fazio, S., Coltorti, F., Palmieri, E. A., Carella, C., Lombardi, G., Saccà, L.
(1998). Reentrant Atrioventricular Nodal Tachycardia Induced by Levothyroxine. J. Clin. Endocrinol. Metab.
83: 2643-2645
[Full Text]
Hermus, A. R., Huysmans, D. A.
(1998). Treatment of Benign Nodular Thyroid Disease. NEJM
338: 1438-1447
[Full Text]
Franklyn, J.A., Maisonneuve, P., Sheppard, M.C., Betteridge, J., Boyle, P.
(1998). Mortality after the Treatment of Hyperthyroidism with Radioactive Iodine. NEJM
338: 712-718
[Abstract][Full Text]
Laurberg, P., Pedersen, K. M., Hreidarsson, A., Sigfusson, N., Iversen, E., Knudsen, P. R.
(1998). Iodine Intake and the Pattern of Thyroid Disorders: A Comparative Epidemiological Study of Thyroid Abnormalities in the Elderly in Iceland and in Jutland, Denmark. J. Clin. Endocrinol. Metab.
83: 765-769
[Abstract][Full Text]
Papini, E., Petrucci, L., Guglielmi, R., Panunzi, C., Rinaldi, R., Bacci, V., Crescenzi, A., Nardi, F., Fabbrini, R., Pacella, C. M.
(1998). Long-Term Changes in Nodular Goiter: A 5-Year Prospective Randomized Trial of Levothyroxine Suppressive Therapy for Benign Cold Thyroid Nodules. J. Clin. Endocrinol. Metab.
83: 780-783
[Abstract][Full Text]
Nordyke, R. A., Reppun, T. S., Madanay, L. D., Woods, J. C., Goldstein, A. P., Miyamoto, L. A.
(1998). Alternative Sequences of Thyrotropin and Free Thyroxine Assays for Routine Thyroid Function Testing: Quality and Cost. Arch Intern Med
158: 266-272
[Abstract][Full Text]
Peran, S., Garriga, M. J., Morreale de Escobar, G., Asuncion, M., Peran, M.
(1997). Increase in Plasma Thyrotropin Levels in Hypothyroid Patients during Treatment due to a Defect in the Commercial Preparation. J. Clin. Endocrinol. Metab.
82: 3192-3195
[Abstract][Full Text]
Woeber, K. A.
(1997). Subclinical Thyroid Dysfunction. Arch Intern Med
157: 1065-1068
[Abstract]
Bauer, D. C., Brown, A. N.
(1996). Sensitive Thyrotropin and Free Thyroxine Testing in Outpatients: Are Both Necessary?. Arch Intern Med
156: 2333-2337
[Abstract]
Krahn, A. D., Klein, G. J., Kerr, C. R., Boone, J., Sheldon, R., Green, M., Talajic, M., Wang, X., Connolly, S.
(1996). How Useful Is Thyroid Function Testing in Patients With Recent-Onset Atrial Fibrillation?. Arch Intern Med
156: 2221-2224
[Abstract]
Vanderpump, M P J, Ahlquist, J A O, Franklyn, J A, Clayton, R N
(1996). Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. BMJ
313: 539-544
[Full Text]